• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nrf2: a potential target for new therapeutics in liver disease.Nrf2:肝脏疾病治疗的新靶点。
Clin Pharmacol Ther. 2012 Sep;92(3):340-8. doi: 10.1038/clpt.2012.110. Epub 2012 Aug 8.
2
Role of Nrf2 in chronic liver disease.Nrf2在慢性肝病中的作用。
World J Gastroenterol. 2014 Sep 28;20(36):13079-87. doi: 10.3748/wjg.v20.i36.13079.
3
Naturally Occurring Nrf2 Activators: Potential in Treatment of Liver Injury.天然存在的Nrf2激活剂:在肝损伤治疗中的潜力。
Oxid Med Cell Longev. 2016;2016:3453926. doi: 10.1155/2016/3453926. Epub 2016 Dec 22.
4
Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis.核因子(红细胞衍生 2 样 2)因子(Nrf2)是一种关键的抗氧化反应调节剂,可预防动脉粥样硬化和非酒精性脂肪性肝炎。
Curr Diab Rep. 2013 Jun;13(3):362-71. doi: 10.1007/s11892-013-0372-1.
5
Liraglutide Ameliorates Lipotoxicity-Induced Oxidative Stress by Activating the NRF2 Pathway in HepG2 Cells.利拉鲁肽通过激活 HepG2 细胞中的 NRF2 通路改善脂毒性诱导的氧化应激。
Horm Metab Res. 2020 Jul;52(7):532-539. doi: 10.1055/a-1157-0166. Epub 2020 May 6.
6
Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.依泽替米贝是一种NPC1L1抑制剂,是一种有效的Nrf2激活剂,可保护小鼠免受饮食诱导的非酒精性脂肪性肝炎。
Free Radic Biol Med. 2016 Oct;99:520-532. doi: 10.1016/j.freeradbiomed.2016.09.009. Epub 2016 Sep 12.
7
Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.核红细胞 2 相关因子 2:肝纤维化的一个新的潜在治疗靶点。
Food Chem Toxicol. 2013 Sep;59:421-7. doi: 10.1016/j.fct.2013.06.018. Epub 2013 Jun 20.
8
Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.姜黄素通过调节肝细胞中的 Nrf2/FXR 信号来减轻乙醇诱导的肝脂肪变性。
IUBMB Life. 2015 Aug;67(8):645-58. doi: 10.1002/iub.1409. Epub 2015 Aug 25.
9
Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms.甜菜碱在肝脏疾病中的预防和治疗作用:分子机制综述。
Eur J Pharmacol. 2021 Dec 5;912:174604. doi: 10.1016/j.ejphar.2021.174604. Epub 2021 Oct 28.
10
Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways.矢车菊素和过氧化物酶体增殖物激活受体激动剂通过 MAPK 和 Nrf2 转导通路对非酒精性脂肪性肝炎介导的氧化应激诱导的细胞毒性的协同作用。
J Agric Food Chem. 2012 Mar 21;60(11):2924-33. doi: 10.1021/jf300005v. Epub 2012 Mar 9.

引用本文的文献

1
Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress.罗沙司他通过上调缺氧诱导因子-1α/解偶联蛋白2对抗氧化应激来改善糖尿病性心肌损伤。
Cardiovasc Diabetol. 2025 Feb 7;24(1):67. doi: 10.1186/s12933-025-02601-2.
2
Mechanism of Action and Related Natural Regulators of Nrf2 in Nonalcoholic Fatty Liver Disease.Nrf2 在非酒精性脂肪性肝病中的作用机制及相关天然调节剂。
Curr Drug Deliv. 2024;21(10):1300-1319. doi: 10.2174/0115672018260113231023064614.
3
Evaluation of the modulating effect of epidermal growth factor receptor inhibitor cetuximab in carbon-tetrachloride induce hepatic fibrosis in rats.评估表皮生长因子受体抑制剂西妥昔单抗对四氯化碳诱导的大鼠肝纤维化的调节作用。
Biochem Biophys Rep. 2024 Mar 21;38:101689. doi: 10.1016/j.bbrep.2024.101689. eCollection 2024 Jul.
4
Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways.哥伦比亚苷通过JAK2/STAT3和JAK2/p38/NF-κB信号通路对D-半乳糖诱导的小鼠肝脏损伤的抗炎作用
Pharmaceuticals (Basel). 2024 Mar 15;17(3):378. doi: 10.3390/ph17030378.
5
Structure-Based Identification of Kelch-like ECH-Associated Protein 1 as a Pharmacological Target of Electrophile-Containing Catechol--Methyltransferase Inhibitors.基于结构鉴定含亲电体儿茶酚-O-甲基转移酶抑制剂的药理学靶点kelch样ECH相关蛋白1
ACS Pharmacol Transl Sci. 2024 Feb 13;7(3):693-706. doi: 10.1021/acsptsci.3c00281. eCollection 2024 Mar 8.
6
A review of experimental and clinical studies on the therapeutic effects of pomegranate () on non-alcoholic fatty liver disease: Focus on oxidative stress and inflammation.石榴对非酒精性脂肪性肝病治疗作用的实验与临床研究综述:聚焦氧化应激与炎症
Food Sci Nutr. 2023 Sep 21;11(12):7485-7503. doi: 10.1002/fsn3.3713. eCollection 2023 Dec.
7
The Roles of NFR2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases.NFR2 调节的氧化应激和线粒体质量控制在慢性肝病中的作用
Antioxidants (Basel). 2023 Oct 29;12(11):1928. doi: 10.3390/antiox12111928.
8
Baicalin attenuated metabolic dysfunction-associated fatty liver disease by suppressing oxidative stress and inflammation via the p62-Keap1-Nrf2 signalling pathway in db/db mice.黄芩苷通过p62-Keap1-Nrf2信号通路抑制db/db小鼠的氧化应激和炎症反应,从而减轻代谢功能障碍相关脂肪性肝病。
Phytother Res. 2025 Apr;39(4):1663-1678. doi: 10.1002/ptr.8010. Epub 2023 Sep 11.
9
Sex difference in the association between blood alcohol concentration and serum ferritin.血液酒精浓度与血清铁蛋白之间关联的性别差异。
Front Psychiatry. 2023 Jul 21;14:1230406. doi: 10.3389/fpsyt.2023.1230406. eCollection 2023.
10
Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels.与非酒精性脂肪性肝病(NAFL)患者相比,非酒精性脂肪性肝炎(NASH)患者的组织中pNRF2、SOCS3、IRF3和RIG1蛋白表达更高:pNRF2表达与空腹血糖水平升高相关。
J Pers Med. 2023 Jul 18;13(7):1152. doi: 10.3390/jpm13071152.

本文引用的文献

1
Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.萝卜硫素通过 NF-E2 相关因子 2 介导的转化生长因子-β/Smad 信号通路抑制减轻肝纤维化。
Free Radic Biol Med. 2012 Feb 1;52(3):671-682. doi: 10.1016/j.freeradbiomed.2011.11.012. Epub 2011 Dec 1.
2
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.氧化应激在非酒精性脂肪性肝炎发病机制中的作用。
Free Radic Biol Med. 2012 Jan 1;52(1):59-69. doi: 10.1016/j.freeradbiomed.2011.10.003. Epub 2011 Oct 13.
3
Protective effects of allopurinol against acute liver damage and cirrhosis induced by carbon tetrachloride: modulation of NF-κB, cytokine production and oxidative stress.别嘌醇对四氯化碳诱导的急性肝损伤和肝硬化的保护作用:对核因子κB、细胞因子产生及氧化应激的调节
Biochim Biophys Acta. 2012 Feb;1820(2):65-75. doi: 10.1016/j.bbagen.2011.09.018. Epub 2011 Oct 7.
4
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.巴多昔芬甲酯、慢性肾脏病与2型糖尿病
N Engl J Med. 2011 Nov 3;365(18):1746; author reply 1746-7. doi: 10.1056/NEJMc1110239.
5
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.巴多昔芬甲基、慢性肾病与2型糖尿病
N Engl J Med. 2011 Nov 3;365(18):1746; author reply 1746-7. doi: 10.1056/NEJMc1110239.
6
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.巴多昔芬甲酯、慢性肾病与2型糖尿病
N Engl J Med. 2011 Nov 3;365(18):1745-6; author reply 1746-7. doi: 10.1056/NEJMc1110239.
7
Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells.丙型肝炎病毒蛋白通过不同的 ROS 依赖和非依赖机制在 HUH7 细胞中激活 NRF2/ARE 通路。
PLoS One. 2011;6(9):e24957. doi: 10.1371/journal.pone.0024957. Epub 2011 Sep 13.
8
Beneficial role of Nrf2 in regulating NADPH generation and consumption.Nrf2 在调节 NADPH 的生成和消耗中的有益作用。
Toxicol Sci. 2011 Oct;123(2):590-600. doi: 10.1093/toxsci/kfr183. Epub 2011 Jul 20.
9
Bardoxolone methyl and kidney function in CKD with type 2 diabetes.巴多索隆甲和 2 型糖尿病 CKD 患者的肾功能。
N Engl J Med. 2011 Jul 28;365(4):327-36. doi: 10.1056/NEJMoa1105351. Epub 2011 Jun 24.
10
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles.KEAP1 敲除和萝卜硫素处理的人乳腺上皮细胞的转录组和蛋白质组谱分析揭示了常见的表达谱。
Breast Cancer Res Treat. 2012 Feb;132(1):175-87. doi: 10.1007/s10549-011-1536-9. Epub 2011 May 20.

Nrf2:肝脏疾病治疗的新靶点。

Nrf2: a potential target for new therapeutics in liver disease.

机构信息

Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.

出版信息

Clin Pharmacol Ther. 2012 Sep;92(3):340-8. doi: 10.1038/clpt.2012.110. Epub 2012 Aug 8.

DOI:10.1038/clpt.2012.110
PMID:22871994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3704160/
Abstract

Nuclear erythroid 2-related factor 2 (Nrf2) is an oxidative stress-mediated transcription factor with a variety of downstream targets aimed at cytoprotection. Nrf2 has recently been implicated as a new therapeutic target for the treatment of liver disease. Here, we focus on the most common liver diseases-nonalcoholic fatty liver disease/steatohepatitis, alcoholic liver disease, and drug-induced liver injury-and highlight areas in the development of these conditions where activation of Nrf2 may alleviate disease progression.

摘要

核红细胞 2 相关因子 2(Nrf2)是一种氧化应激介导的转录因子,具有多种下游靶标,旨在实现细胞保护。Nrf2 最近被认为是治疗肝脏疾病的新的治疗靶点。在这里,我们重点关注最常见的肝脏疾病——非酒精性脂肪性肝病/肝炎、酒精性肝病和药物性肝损伤,并强调在这些疾病的发展过程中,激活 Nrf2 可能会缓解疾病进展的领域。